Student Spotlight: Chief Scientist Helps Broaden Biotechnology Field
Bit Bio, the U.K.-based startup, only needed three weeks to raise $41.5 million in a Series A funding round that will be used to support the company’s goal to transition biology into engineering. This synthetic biology team was founded by stem cell biologist and neurosurgeon, Mark Kotter, in 2016 to commercialize biotechnology that can reduce …